Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
- Journal
- PubMed
In The Last Decade
doi.org/w68387165 →Countries where authors are citing Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
This map shows the geographic impact of Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). more than expected).
Fields of papers citing Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
This network shows the impact of Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine)..
About Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
This paper, published in 1990, received 601 indexed citations . Written by Larry W. Hertel, G B Boder, Julian S. Kroin, Sharon M. Rinzel, Gerald A. Poore, Glen C. Todd and Gerald B. Grindey covering the research area of Molecular Biology and Oncology. It is primarily cited by scholars working on Oncology (325 citations), Molecular Biology (249 citations) and Pulmonary and Respiratory Medicine (115 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w68387165.